Maverick Capital’s Select Medical SEM Stock Holding History

Maverick Capital’s Portfolio SEM Stock Details SEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-10,394	Closed	-$97K	–	289
2018 Q1	$97K	Buy	+10,394	New	+$99K	﹤0.01%	218

Other funds holding SEM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return

Maverick Capital's SEM Position: Q2 2018 in Review

Maverick Capital sold out of Select Medical (SEM) in Q2 2018, closing a stake of 10,394 shares — an estimated $97K sold.

Maverick Capital first reported a position in SEM in Q1 2018 and held it in 1 quarter. The position peaked at $97K in Q1 2018. 198 funds tracked by Wall St. Rank hold SEM as of Q2 2018.

Maverick Capital reported no remaining Select Medical position as of Q2 2018 after selling out during the quarter.
Maverick Capital sold 10,394 Select Medical shares in Q2 2018, an estimated $97K.
Maverick Capital first reported a position in Select Medical in Q1 2018 and held it in 1 quarter.
Maverick Capital's Select Medical position peaked at $97K in Q1 2018.
198 funds tracked by Wall St. Rank held Select Medical as of Q2 2018.

Based on Maverick Capital's 13F filing for Q2 2018, filed 14 Aug 2018.